Form 8-K - Current report:
SEC Accession No. 0001104659-25-055958
Filing Date
2025-06-03
Accepted
2025-06-03 16:05:38
Documents
12
Period of Report
2025-05-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516903d1_8k.htm   iXBRL 8-K 31101
  Complete submission text file 0001104659-25-055958.txt   197939

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA irwd-20250528.xsd EX-101.SCH 3032
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20250528_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20250528_pre.xml EX-101.PRE 22370
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2516903d1_8k_htm.xml XML 3686
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 251019369
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)